BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BridgePoint Medical Announces Licensing Agreement for its Peripheral Vascular Products


1/18/2012 10:07:46 AM

MINNEAPOLIS, Jan. 17, 2012 /PRNewswire/ -- BridgePoint Medical®, Inc., a developer of innovative Chronic Total Occlusion interventional cardiology and peripheral vascular devices, today announced that it has signed definitive agreements to exclusively license the rights to its peripheral vascular products including BigBoss Catheter, Mantaray Catheters and the Mantaray Guidewire to Covidien. Covidien, a leading global provider of healthcare products, will also acquire certain manufacturing assets from the company. The terms of the agreement were not disclosed.

"This is a fantastic achievement for BridgePoint Medical," said Denis Harrington, Chief Executive Officer and President, BridgePoint Medical. "We are pleased with this transaction and expect that this agreement will be a positive development for all BridgePoint Shareholders."

The bulk of BridgePoint Medical's assets including the coronary Chronic Total Occlusion (CTO) products, intellectual property, its employees, and all other non-vascular applications will remain with the company.

Chad Kugler, BridgePoint's Co-Founder, Chief Operating Officer and primary inventor of BridgePoint's technology added, "This is a culmination of five years of hard work by all of BridgePoint's employees. The successful completion of these agreements further validates the significant commercial success BridgePoint has had with our coronary CTO products and leaves us in a financially strong position to build on that success. Our future is very bright."

About BridgePoint Medical

BridgePoint Medical, Inc. is a privately held company established in 2006 to design, develop and commercialize new technologies and techniques to treat challenging coronary artery disease. Investors include New Enterprise Associates, Polaris Venture Partners, Foundation Medical Partners and Michael Berman.

SOURCE BridgePoint Medical, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES